Skip to main content
Clinical Trials/JPRN-UMIN000007732
JPRN-UMIN000007732Completed未知

A randomized parallel-group trial of propofol versus midazolam for sadation during ERCP - A randomized trial of propofol sadation during ERCP

Hiroshima University hospital0 sites100 target enrollmentStarted: April 30, 2012Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1. Patients who are deemed inappropriate to sedation because of bad general ccondition 2. Patients with severe cardiovascular or respiratory disorder 3. Patients who have decompensated liver cirrhosis 4. Patients who have experienced a serious adverse effect by propofol or midazolam 5. Patient with known contraindications for propofol or midazolam 6. Pregnant or potentially pregnant women 7. Other patients who are in the opinion of the caring investigator unfit for enrollment in the study

Investigators

Similar Trials

Completed
Phase 2
Comparison blood glucose change in intravenous anesthesia with Propofol and inhalation anesthesia with Isofluran in child between 4-6 years old that candidate for dental procedure in general anesthesia.blood glucose change.Hypoglycemia (spontaneous) - drug- induced
IRCT201109034224N17Vice Chancellery for Research of Dental College- Islamic Azad University of Khorasgan26
Active, not recruiting
Not Applicable
A randomized study to evaluate whether there is a difference in survival between two different forms of anaesthesia. The study will evaluate patients that are scheduled for a surgery for either breast-, colon- or rectalcancer.Patients with breast- or colorectal cancer that will undergo radical surgery for this cancer. During the surgery general aneasthesia with either propofol or sevoflurane will be used.MedDRA version: 14.1Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10009944Term: Colon cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2013-002380-25-SECKF at Västmanlands hospital Västerås
Active, not recruiting
Phase 1
A randomized study to evaluate whether there is a difference in survival between two different forms of anaesthesia. The study will evaluate patients that are scheduled for a surgery for either breast-, colon- or rectalcancer.Patients with breast- or colorectal cancer that will undergo radical surgery for this cancer. During the surgery general aneasthesia with either propofol or sevoflurane will be used.MedDRA version: 20.0Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10009944Term: Colon cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2013-002380-25-HRCKF at Västmanlands hospital Västerås8,000
Not yet recruiting
Not Applicable
A clinical trial to study the effects of two drugs, propofol and etomidate on blood pressure, seizure duration, and recovery profile during electro - convulsive therapy.
CTRI/2019/03/018031SVIMS University
Completed
Phase 4
It is a study to compare the effectiveness of two anaesthesia techniques in reducing postoperative nausea and vomiting in female patients undergoing laparoscopic surgery using propofol in one and combination of propofol and sevoflurane as maintenance agents in another
CTRI/2019/09/021449Department of anaesthesiology70